Bionano Genomics : FINAL SPEAKERS FOR BIONANO GENOMICS 2022 VIRTUAL SYMPOSIUM

FINAL SPEAKERS FOR BIONANO GENOMICS 2022 VIRTUAL SYMPOSIUM

January 7, 2022

Share

Bionano Genomics is excited to share the exceptional speaker line up for its 2022 Symposium, beginning this Monday, January 10. This year's four-day event will feature 31 oral presentations from 27 different speakers from prominent institutions across North America and Europe.

Register today to join us as leading researchers share their latest discoveries in optical genome mapping in constitutional cytogenomics, hematologic malignancies, solid tumors and in combination with next-generation sequencing (NGS). All are welcome; registration is free.

The virtual event runs next week, Monday, January 10 through Thursday, January 13, 2022. Each day will feature speaker presentations, a live panel with Q&A and a scientific poster exhibit within the virtual exhibition hall.

Full speaker line up:

Monday, January 10: Constitutional Cytogenomics

Speaker Name	Institution	State / Country	Talk Title
Chaim Jalas	The Foundation for Embryonic Competence	New Jersey, USA	Validation of Optical Genome Mapping for Preimplantation Genetic Analysis - Structural Rearrangement (PGD-SR) Applications
Dr. Laila El-Khattabi	Assistance Publique-Hôpitaux de Paris (AP-HP) - Université de Paris	Paris, France	Balanced Translocations Associated with Male Infertility: How Optical Genome Mapping Could Lead to New Discoveries?
Dr. Shirley Heggarty	Belfast Health and Social Care Trust	Belfast, UK	Clinical Utility of Optical Genome Mapping in a Constitutional Cytogenetics Laboratory
Dr. Alexander Hoischen	Radboud University Medical Center	Nijmegen, Netherlands	Optical Genome Mapping: Mapping Difficult Structural Variant Types - Repeat Expansions
Dr. Anwar Iqbal	University of Rochester Medical Center	New York, USA	Validation Study of Optical Genome Mapping for Postnatal and Prenatal Clinical Research According to Established NYSDOH Guidelines
Dr. Nikhil Sahajpal	Augusta University	Georgia, USA	Enhanced Structural Variation Detection with OGM in Constitutional Disorders

Tuesday, January 11: Hematologic Malignancies

Speaker Name	Institution	State / Country	Talk Title
Bence Dvorak	University Children's Hospital Zurich- Eleonore Foundation	Zurich, Switzerland	Characterization of Plasma Cell Dyscrasias (PCD) by Optical Genome Mapping
Dr. Jonathan L. Lühmann	Hannover Medical School	Hannover, Germany	The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia
Dr. Anna Puiggros	Hospital del Mar	Barcelona, Spain	The Hidden Side of Genomic Complexity: Learning from OGM in Chronic Lymphocytic Leukemia
Dr. Barbara Dewaele	University Hospitals Leuven	Leuven, Belgium	Opportunities of Optical Genome Mapping for Genetic Diagnosis in Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia
Dr. Kornelia Neveling	Radboud University Medical Center	Nijmegen, Netherlands	Technical and Clinical Validation of Optical Genome Mapping
Dr. Elena García Sánchez	Hospital Infantil Universitario Niño Jesús	Madrid, Spain	Optical Genome Mapping for Diagnosis of Paediatric Leukaemia
Dr. Brynn Levy	Columbia University Medical Center	New York, USA	Assessing Genomic Aberrations in AML using Optical Genome Mapping: Insights from a National Multi-Center Study
Dr. Adrian Dubuc	Harvard Medical School Brigham and Women's Hospital	Massachusetts, USA	Shining a New Light on Cancer Cytogenetics: Leveraging Novel Technological Approaches for Improved Understanding in B-ALL
Dr. Adam C. Smith	Laboratory Medicine Program, University Health Network, University of Toronto	Toronto, Canada	A Year in Review: Parallel Testing of Hematologic Malignancies Using Optical Genome Mapping Compared to Conventional Cytogenetics
Dr. Saurabh Gupta	Quest Diagnostics	New Jersey, USA	Optical genome mapping: Utility for stratification of B-CLL by accurate identification of clinically relevant structural variants

Wednesday, January 12: Solid Tumors

Speaker Name	Institution	Talk Title
Dr. Elena García Sánchez	Hospital Infantil Universitario Niño Jesús	Madrid, Spain	Optical Genome Mapping: Application for Analysis of Non-Haematological Cancers
Dr. Tuomo Mantere	University of Oulu, Finland	Oulu, Finland	Optical Genome Mapping in Unexplained High-Risk Breast Cancer Families
Dr. Gopalrao Velagaleti	UT Health - San Antonio	Texas, USA	Vigor and Reproducibility in Research: The Cell Line Saga: Is OGM the Answer?
Dr. Matthew Brian Couger	Brigham and Women's Hospital	Massachusetts, USA	The Chromosomal Landscape of Mesothelioma
Dr. Juan Diaz Martin	Instituto de Biomedicina de Sevilla (IBiS)	Sevilla, Spain	Complex Rearrangement Patterns in Undifferentiated Small Round Cell Sarcomas Associated with Poor Outcomes in Clinical Research
Dr. Ravindra Kolhe	Medical College of Georgia at Augusta University	Georgia, USA	Utility of Optical Genome Mapping for the Chromosomal Characterization of Solid Tumors

Thursday, January 13: OGM + NGS

Speaker Name	Institution	Talk Title
Dr. Kornelia Neveling	Radboud University Medical Center	Nijmegen, Netherlands	Optical Genome Mapping: Different Types of Hidden SV's in Families with Inherited Retinal Diseases
Dr. Mariangela Sabatella	Princess Máxima Center for Pediatric Oncology	Utrecht, Netherlands	Enlightening the Dark Matter of the Genome: OGM Identifies a Germline Retrotransposon Insertion in SMARCB1 in Two Siblings with Atypical Teratoid Rhabdoid Tumors
Dr. Gordana Raca	Children's Hospital Los Angeles	California, USA	OGM and Capture-Based RNA-Seq Enable Comprehensive Genomic Characterization of Pediatric B-lymphoblastic Leukemias
Arran Constantine	bit.bio	Cambridge, UK	Cytogenetic QC at bit.bio: How a Next-Generation Cytogenetics Platform Enhances Quality Control of Next-Generation Cells
Dr. Saumyaa Saumyaa	AstraZeneca	Cambridge, UK	Detection and Characterization of On- and Off-target Integration of Foreign DNA in the Host Genomes, for Therapeutic Cell and Gene Therapy Development, Using OGM
Dr. Laila El-Khattabi	Assistance Publique-Hôpitaux de Paris (AP-HP) - Université de Paris	Paris, France	Molecular Characterization of Genome Structural Variants in Developmental Disorders: Comparison Between OGM and Short Read WGS
Dr. Jens Luebeck	University of California, San Diego	California, USA	Combined NGS and OGM Reveal the Complex Structures of Circular Extrachromosomal DNA and other Focal Amplifications in Cancer Genomes
Dr. Ravindra Kolhe	Medical College of Georgia at Augusta University	Georgia, USA	Clinical Utility of Combined Optical Genome Mapping and Comprehensive Genomic Sequencing in Robust Evaluation of Hematological Cancers
Dr. Rashmi Kanagal Shamana	MD Anderson Cancer Center	Texas, USA	A Comprehensive Assessment of a Large MDS Cohort at MD Anderson Cancer Center Using Optical Genome Mapping and a Targeted NGS Panel

Symposium registration is open to all and there is no charge for attending this event.Register today!

Share